Full-dose sofosbuvir plus low-dose ribavirin for hepatitis C virus genotype 2-infected patients on hemodialysis.

Conclusions: In hemodialysis patients with HCV GT2 infection, the full-dose SOF plus low-dose RBV regimen appears to be safe and well tolerated, and yields high rates of sustained virologic response. PMID: 31064176 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31064176?dopt=Abstract

Source: The Korean Journal of Internal Medicine - May 9, 2019 Category: Internal Medicine Authors: Seo HY, Seo MS, Yoon SY, Choi JW, Ko SY Tags: Korean J Intern Med Source Type: research